Finance

Lists
600332:SHA
Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CNÂ¥20.42
-0.20%
(-0.040) 1D
Aug 28, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600332...
Open
CNÂ¥20.40
High
CNÂ¥20.45
Low
CNÂ¥20.27
Mkt. cap
31.36B
Avg. vol.
11.07M
Volume
4.96M
Dividend
4.16%
Quarterly dividend
CNÂ¥0.21
Ex-dividend date
Jun 16, 2026
P/E ratio
11.27
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.30
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
27K
Open
CNÂ¥20.40
High
CNÂ¥20.45
Low
CNÂ¥20.27
Mkt. cap
31.36B
Avg. vol.
11.07M
Volume
4.96M
Dividend
4.16%
Quarterly dividend
CNÂ¥0.21
Ex-dividend date
Jun 16, 2026
P/E ratio
11.27
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.30
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
27K
News stories
From web sources and news partners
About Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CEO-
Employees27.1K
FoundedSep 1, 1997
Headquarters-
SectorHealth care provider
Websitegybys.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.77B
16.05B
23.28B
18.81B
Cost of goods sold
16.58B
14.37B
18.55B
16.27B
Cost of revenue
16.58B
14.37B
18.55B
16.27B
Research and development expenses
158.44M
217.91M
158.68M
184.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.88B
2.21B
2.22B
1.85B
Operating expense
2.05B
2.50B
2.55B
1.99B
Total operating expenses
18.63B
16.87B
21.10B
18.26B
Operating income
1.14B
-820.04M
2.18B
548.57M
Other non operating income
83.07M
-100.40M
-1.28M
-282.29M
EBT including unusual items
1.09B
-494.18M
2.21B
393.99M
EBT excluding unusual items
1.24B
-825.17M
2.21B
415.13M
Income tax expense
271.49M
-156.77M
383.93M
59.00M
Effective tax rate
24.82%
31.72%
17.39%
14.97%
Other operating expenses
-46.93M
164.17M
91.90M
45.62M
Net income
793.91M
-326.94M
1.78B
312.16M
Net profit margin
4.02%
-2.04%
7.66%
1.66%
Earnings per share
-
-
-
-
Interest and investment income
117.54M
187.01M
140.88M
148.85M
Interest expense
-101.91M
-95.60M
-103.44M
-
Net interest expenses
15.64M
91.41M
37.44M
148.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.29B
-660.36M
2.34B
730.07M
Gain or loss from assets sale
3.63M
-107.74M
-
-938.61K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps